Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:57 +0200Thu, 04 Jul 2024 11:35:00 +0200Nexavar : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0690-steps-after_en.pdfNexavar : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0690-steps-after_en.pdfThu, 04 Jul 2024 11:35:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nexavarHuman medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nexavarFri, 07 Jun 2024 14:57:00 +0200Human medicine